ECM
NVAX icon

ETrade Capital Management’s Novavax NVAX Stock Holding History

ETrade Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$278K Buy
+2,567
New +$313K 0.01% 739

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ETrade Capital Management's NVAX Position: Q3 2020 in Review

ETrade Capital Management opened a new position in Novavax (NVAX) in Q3 2020: 2,567 shares worth $278K. The stake represents 0.01% of the portfolio and ranks #739 among its holdings.

311 funds tracked by Wall St. Rank hold NVAX as of Q3 2020.

  • ETrade Capital Management held 2,567 shares of Novavax worth $278K as of Q3 2020.
  • Novavax was a new ETrade Capital Management position in Q3 2020.
  • Novavax made up 0.01% of ETrade Capital Management's portfolio in Q3 2020, its #739 holding.
  • 311 funds tracked by Wall St. Rank held Novavax as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.